Appetite-suppressing drugs could wipe out millions of fast-food trips. What it means for your choices and your money.

INSM eyes the next steps as TPIP hits all endpoints in the PAH study, setting the stage for late-stage trials and broader potential in lung disease.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

McDonald’s stock was heading for its longest losing streak in 12 years after Redburn Atlantic recommended investors sell due ...

Here's why McDonald's is more exposed than other fast-food brands to shifts in eating habits as a result of weight-loss drugs ...